undamentalytics Newsletter

Beyond Meat vs Medifast

Medifast is the larger business, with $386m of revenue in fiscal 2025 against $275m for Beyond Meat (1.4 times as much). Beyond Meat grew faster (-15.6% against -36.0%). Beyond Meat kept more of each dollar of sales as profit: a net margin of 79.5% against -4.8%.

Latest fiscal yearBeyond MeatBYND, 2025MedifastMED, 2025
Revenue $275m $386m
Revenue growth -15.6% -36.0%
Net income $219m −$18.7m
Operating margin -121.1% -3.7%
Net margin 79.5% -4.8%
Return on equity — -9.1%
Free cash flow −$157m $1.2m
Cash $204m $89.3m
Total debt $416m $0
Debt to equity — 0.0%
Dividend per share — —
Dividend yield — 0.1%
Share buybacks — $0
Employees 589 380
Market value $3.69bn $141m
Price vs our value range — Below our value range
Moat score 13 (Weak) 75 (Strong)
Insider trades, 12 months 0 buys, 4 sales 13 buys, 2 sales

Each figure is from the company's latest annual report and links to the page it comes from. Fiscal years can end on different dates. Market value and the value verdict use the delayed price shown on the stock pages. Not a recommendation.

Go deeper

Figures from each company's latest annual report filed with the SEC (10-K or 20-F), as reported, with the fiscal year shown. Not investment advice. How we read filings: methodology.